Get Your Team Back to Work
Add COVID-19 Antibody Testing as Part of your Employee Return-to-Work Program
Many companies have implemented antibody testing as part of their phased, employee return-to-work strategy. According to the latest CDC Guidance the presence of antibodies, detectable several weeks after symptom onset, “suggests that infectiousness likely is greatly decreased and that some degree of immunity from future infection has developed”
(Review full Guidance for further details)
About 20/20 GeneSystems
20/20 GeneSystems is a U.S. based digital diagnostics company that harnesses the power of A.I. and big data analytics to reduce cancer mortality around the world through early detection. We have created innovative tests built around our proprietary algorithms to detect more than 6 common cancers. In the US, we also operate our own CLIA certified laboratory, catering to the needs of US consumers in our home market. We currently operate globally through partners, in Asia, the Middle East and Europe.
20/20 also has a proud history spanning almost 20 years of assisting first responders through innovative cancer screening as well as other biotech products.
Why Partner with 20/20 GeneSystems?
- We provide 3 different types of testing solutions
- We offer cooperative advertising programs